Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ctDNA as a biomarker of progression in oesophageal adenocarcinoma.

ESMO open - 1 Jun 2022

Bonazzi V F, Aoude L G, Brosda S, Lonie J M, Patel K, Bradford J J, Koufariotis L T, Wood S, Smithers B Mark, Waddell N, Barbour A P

Abstract excerpt

BACKGROUND: The incidence of oesophageal adenocarcinoma (OAC) is rapidly increasing and despite improvements in treatment, the 5-year survival rate remains poor. Prognostic biomarkers that address the genomic heterogeneity in this highly complex disease will aid the development of precision therapeutics and improve patient survival. The aim of this study was to determine whether circulating tumour DNA (ctDNA) has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Esophageal Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35798469
DOI: 10.1016/j.esmoop.2022.100452
PMCID: PMC9271467

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ctDNA as a biomarker of progression in oesophageal adenocarcinoma.PMID 35798469Read ↗

ctDNA as A Biomarker of Progression in Oesophageal AdenocarcinomaSemantic proximity Read ↗

Molecular residual disease detection by serial tumour-informed circulating tumour DNA analysis in resectable oesophageal & gastroesophageal junctional adenocarcinoma: a prospective UK multi-centre studySemantic proximity Read ↗

Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.Semantic proximity Read ↗

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy.Semantic proximity Read ↗

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity Read ↗

A compendium of genetic drivers for oesophageal adenocarcinoma defines prognostic and therapeutic biomarkers for use in the clinicSemantic proximity Read ↗

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.Semantic proximity Read ↗

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.Semantic proximity Read ↗

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.Semantic proximity Read ↗

Gene-specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort study.Semantic proximity Read ↗

Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapySemantic proximity Read ↗

Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.